Literature DB >> 24814310

p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease.

Tobias Leibold1, Vanessa W Hui1, Jinru Shia2, Jeannine A Ruby1, Elyn R Riedel3, José G Guillem4.   

Abstract

BACKGROUND: Expression profiles of p21, p27, p53, Ki-67, and thymidylate synthase may be associated with response to neoadjuvant chemoradiation. The relationship between post-treatment protein expression and regional lymph node involvement has not been fully explored.
METHODS: Tumor cores from 126 rectal cancer patients underwent immunohistochemical analysis for the aforementioned proteins. Staining indices (SIs) using percentage of stained cells and staining intensity were calculated for 10 tumor cores per patient. SI for each marker was compared between node negative and node positive patients.
RESULTS: Twenty-six (20.6%) cancer patients had a pathologic complete response and 37 had inadequate tissue or cancer cells, leaving 63 for analysis. Thirty-seven (58.7%) cancer patients were node negative and 26 (41.3%) were node positive. There was an association between increased p27 SI and nodal positivity (P = .04).
CONCLUSION: Increased p27 expression in post-treatment rectal cancer is associated with nodal positivity and may determine which patients are suitable for local excision.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymph node positivity; Molecular marker; Post-treatment rectal cancer; Tissue microarray

Mesh:

Substances:

Year:  2014        PMID: 24814310      PMCID: PMC7104916          DOI: 10.1016/j.amjsurg.2014.02.003

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  54 in total

1.  High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Kyubo Kim; Eui Kyu Chie; Hong-Gyun Wu; Sang Gyun Kim; Seung-Hee Lee; Gyeong Hoon Kang; Chang Lim Hyun; Sung W Ha
Journal:  Int J Colorectal Dis       Date:  2011-03-19       Impact factor: 2.571

2.  A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

Authors:  Julio Garcia-Aguilar; Qian Shi; Charles R Thomas; Emily Chan; Peter Cataldo; Jorge Marcet; David Medich; Alessio Pigazzi; Samuel Oommen; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2011-07-14       Impact factor: 5.344

3.  Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.

Authors:  A Grann; C Feng; D Wong; L Saltz; P P Paty; J G Guillem; A M Cohen; B D Minsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

4.  p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.

Authors:  P Luna-Perez; E L Arriola; Y Cuadra; I Alvarado; A Quintero
Journal:  Ann Surg Oncol       Date:  1998 Apr-May       Impact factor: 5.344

5.  Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.

Authors:  Benjamin R Tan; Fabienne Thomas; Robert J Myerson; Barbara Zehnbauer; Kathryn Trinkaus; Robert S Malyapa; Matthew G Mutch; Elliot E Abbey; Amer Alyasiry; James W Fleshman; Howard L McLeod
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

6.  Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.

Authors:  E Lezoche; M Guerrieri; A M Paganini; M Baldarelli; A De Sanctis; G Lezoche
Journal:  Br J Surg       Date:  2005-12       Impact factor: 6.939

7.  Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers.

Authors:  L Ruo; J G Guillem; B D Minsky; S H Q Quan; P B Paty; A M Cohen
Journal:  Int J Colorectal Dis       Date:  2002-01       Impact factor: 2.571

8.  Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.

Authors:  Harvey G Moore; Jinru Shia; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Gary K Schwartz; Bruce D Minsky; Leonard Saltz; Jose G Guillem
Journal:  Ann Surg Oncol       Date:  2004-10-15       Impact factor: 5.344

9.  Long-term survival after transanal excision of T1 rectal cancer.

Authors:  Garrett M Nash; Martin R Weiser; José G Guillem; Larissa K Temple; Jinru Shia; Mithat Gonen; W Douglas Wong; Philip B Paty
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

10.  Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Federica Bertolini; Carmelo Bengala; Luisa Losi; Maria Pagano; Francesco Iachetta; Cristina Dealis; Gordana Jovic; Roberta Depenni; Sandra Zironi; Anna Maria Falchi; Gabriele Luppi; Pier Franco Conte
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-18       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.